The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.

In the latest trading session, Cardinal Health (CAH) closed at $208.26, marking a +2.83% move from the previous day.

Cardinal Health (NYSE:CAH) today provided an update to its financial outlook for fiscal year 2026 and plans to highlight ...

Cardinal Health has introduced ContinuCare Pathway, a pharmacy-to-supplier referral pathway program designed to help retail ...

The drug distributors continue to relentlessly climb higher. There’s nothing, you know, people hate the pharma middleman.

Drug distributor Cardinal Health on Tuesday forecast 2026 adjusted profit to be at least $10 per share, compared with its ...

Cardinal Health (CAH) is drawing fresh attention as investors reassess its recent share performance alongside the company’s scale, with revenue of US$234.3b and net income of US$1.6b from its ...

Cardinal Health is building its drug distribution portfolio with the acquisition of Kinray, Inc., a Whitestone, N.Y.-based privately held distributor of branded and generic medicines to more than ...